These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36891156)

  • 1. Plerixafor and resatorvid inhibit hepatitis B virus
    Cai J; Li Y; Hu P; Xu R; Yuan H; Zhang W; Feng T; Liu R; Li W; Zhu C
    Front Cell Infect Microbiol; 2023; 13():1118801. PubMed ID: 36891156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effect of small-molecule compound AM679 targeting elongation-factor binding protein 2 on hepatitis B virus in vitro].
    Fang HJ; Cai JY; Hou XX; Song JL; Peng LY; Zhu CL
    Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):318-324. PubMed ID: 38733186
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of Elongation Factor Tu GTP-binding Domain-containing 2 Gene
    Tian A; Li Y; Fan H; Hu P; Xu R; Yuan H; Cai J; Zhang W; Yue M; Li J; Dong C; Zhu C
    Immunol Invest; 2022 Jul; 51(5):1485-1497. PubMed ID: 34436958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
    Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
    Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
    J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nobiletin, a novel inhibitor, inhibits HBsAg production and hepatitis B virus replication.
    Hu Z; Hu J; Ren F; Xu H; Tan M; Wang Q; Ren J
    Biochem Biophys Res Commun; 2020 Mar; 523(3):802-808. PubMed ID: 31954513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niacin analogue, 6-Aminonicotinamide, a novel inhibitor of hepatitis B virus replication and HBsAg production.
    Ren F; Yang X; Hu ZW; Wong VKW; Xu HY; Ren JH; Zhong S; Jia XJ; Jiang H; Hu JL; Cai XF; Zhang WL; Yao FL; Yu HB; Cheng ST; Zhou HZ; Huang AL; Law BYK; Chen J
    EBioMedicine; 2019 Nov; 49():232-246. PubMed ID: 31680002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
    König A; Yang J; Jo E; Park KHP; Kim H; Than TT; Song X; Qi X; Dai X; Park S; Shum D; Ryu WS; Kim JH; Yoon SK; Park JY; Ahn SH; Han KH; Gerlich WH; Windisch MP
    J Hepatol; 2019 Aug; 71(2):289-300. PubMed ID: 31077792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
    Marchetti AL; Zhang H; Kim ES; Yu X; Jang S; Wang M; Guo H
    J Virol; 2022 Jan; 96(2):e0136021. PubMed ID: 34705558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo.
    Zhao Z; Hong W; Zeng Z; Wu Y; Hu K; Tian X; Li W; Cao Z
    J Biol Chem; 2012 Aug; 287(36):30181-90. PubMed ID: 22791717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.
    Liu Y; Yao W; Si L; Hou J; Wang J; Xu Z; Li W; Chen J; Li R; Li P; Bo L; Xiao X; Lan J; Xu D
    Antiviral Res; 2018 Jul; 155():39-47. PubMed ID: 29702120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-hepatitis B virus activity of swertisin isolated from Iris tectorum Maxim.
    Xu HY; Ren JH; Su Y; Ren F; Zhou YJ; Jiang H; Cheng ST; Zhang CR; Chen J
    J Ethnopharmacol; 2020 Jul; 257():112787. PubMed ID: 32224198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation.
    Tanaka T; Okuyama-Dobashi K; Murakami S; Chen W; Okamoto T; Ueda K; Hosoya T; Matsuura Y; Ryo A; Tanaka Y; Hagiwara M; Moriishi K
    Antiviral Res; 2016 Sep; 133():156-64. PubMed ID: 27515132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZNF148 inhibits HBV replication by downregulating RXRα transcription.
    Yao X; Xu K; Tao N; Cheng S; Chen H; Zhang D; Yang M; Tan M; Yu H; Chen P; Zhan Z; He S; Li R; Wang C; Wu D; Ren J
    Virol J; 2024 Jan; 21(1):35. PubMed ID: 38297280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
    Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
    Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Junceellolide B, a novel inhibitor of Hepatitis B virus.
    Li X; Liu H; Cheng W; Wang J; Zhang H; Lu F; Chen X; Lin W
    Bioorg Med Chem; 2020 Aug; 28(16):115603. PubMed ID: 32690259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HBV therapeutic potential of small molecule 3,5,6,7,3',4'-Hexamethoxyflavone in vitro and in vivo.
    Tan M; Ren F; Yang X
    Virology; 2021 Aug; 560():66-75. PubMed ID: 34051476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
    Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
    J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX9 represses hepatitis B virus replication through binding to HBV EnhII/Cp and inhibiting the promoter activity.
    Yang H; Zhou Y; Mo J; Xiang Q; Qin M; Liu W; Shang J; Yang Q; Xu W; Yang G; Tan Q; Wu K; Liu Y; Wu J
    Antiviral Res; 2020 May; 177():104761. PubMed ID: 32147495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.